These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9353692)

  • 1. Pharmacokinetic-pharmacodynamic modeling of doxacurium: effect of input rate.
    Zhu Y; Audibert G; Donati F; Varin F
    J Pharmacokinet Biopharm; 1997 Feb; 25(1):23-37. PubMed ID: 9353692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependency of pharmacokinetic/pharmacodynamic parameters after intravenous bolus doses of cisatracurium.
    Chen C; Yamaguchi N; Varin F
    Br J Anaesth; 2008 Dec; 101(6):788-97. PubMed ID: 18974056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An interstitial compartment is necessary to link the pharmacokinetics and pharmacodynamics of mivacurium.
    Schiere S; Proost JH; Roggeveld J; Wierda M
    Eur J Anaesthesiol; 2004 Nov; 21(11):882-91. PubMed ID: 15717705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose response, recovery, and cost of doxacurium as a continuous infusion in neurosurgical intensive care unit patients.
    Prielipp RC; Robinson JC; Wilson JA; MacGregor DA; Scuderi PE
    Crit Care Med; 1997 Jul; 25(7):1236-41. PubMed ID: 9233753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic modeling of atracurium in intensive care patients.
    Farenc C; Lefrant JY; Audran M; Bressolle F
    J Clin Pharmacol; 2001 Jan; 41(1):44-50. PubMed ID: 11144993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mivacurium arteriovenous gradient during steady state infusion in anesthetized patients.
    Ezzine S; Donati F; Varin F
    Anesthesiology; 2002 Sep; 97(3):622-9. PubMed ID: 12218529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of doxacurium in normal patients and in those with hepatic or renal failure.
    Cook DR; Freeman JA; Lai AA; Robertson KA; Kang Y; Stiller RL; Aggarwal S; Abou-Donia MM; Welch RM
    Anesth Analg; 1991 Feb; 72(2):145-50. PubMed ID: 1824669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of renal function on the pharmacokinetics and pharmacodynamics and simulated time course of doxacurium.
    Fisher DM; Reynolds KS; Schmith VD; Hsu J; Sokoll MD; Lennon RL; Caldwell JE
    Anesth Analg; 1999 Sep; 89(3):786-95. PubMed ID: 10475326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of doxacurium chloride. A new long-acting nondepolarizing muscle relaxant.
    Basta SJ; Savarese JJ; Ali HH; Embree PB; Schwartz AF; Rudd GD; Wastila WB
    Anesthesiology; 1988 Oct; 69(4):478-86. PubMed ID: 2972233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral link model as an alternative for pharmacokinetic-pharmacodynamic modeling of drugs having a very short elimination half-life.
    Laurin J; Donati F; Nekka F; Varin F
    J Pharmacokinet Pharmacodyn; 2001 Feb; 28(1):7-25. PubMed ID: 11253615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, randomized, multicenter study of doxacurium vs. pancuronium in intensive care unit patients who require neuromuscular-blocking agents.
    Murray MJ; Coursin DB; Scuderi PE; Kamath G; Prough DS; Howard DM; Abou-Donia MA
    Crit Care Med; 1995 Mar; 23(3):450-8. PubMed ID: 7874894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of doxacurium during normothermic and hypothermic cardiopulmonary bypass surgery.
    Asokumar B; Cheng D; Chung F; Peniston C; Sandler A; Varin F
    Can J Anaesth; 1998 Jun; 45(6):515-20. PubMed ID: 9669003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relations of doxacurium and its reversal with neostigmine in young adults and healthy elderly patients.
    Koscielniak-Nielsen ZJ; Law-Min JC; Donati F; Bevan DR; Clement P; Wise R
    Anesth Analg; 1992 Jun; 74(6):845-50. PubMed ID: 1534472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of doxacurium chloride.
    Maddineni VR; Cooper R; Stanley JC; Mirakhur RK; Clarke RS
    Anaesthesia; 1992 Jul; 47(7):554-7. PubMed ID: 1385680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular effects of doxacurium chloride in isoflurane-anesthetized dogs.
    Martinez EA; Wooldridge AA; Hartsfield SM; Mealey KL
    Vet Surg; 1998; 27(3):279-83. PubMed ID: 9605239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of aging on the pharmacokinetics and pharmacodynamics of doxacurium.
    Gariepy LP; Varin F; Donati F; Salib Y; Bevan DR
    Clin Pharmacol Ther; 1993 Mar; 53(3):340-7. PubMed ID: 8453853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of mivacurium and doxacurium versus vecuronium in the isolated forearm.
    Campkin NT; Hood JR; Feldman SA
    Anaesthesia; 1994 Jun; 49(6):501-2. PubMed ID: 7912478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic variables of mivacurium chloride after intravenous administration in dogs.
    Smith LJ; Schwark WS; Cook DR; Moon PF; Looney AL
    Am J Vet Res; 1999 Sep; 60(9):1051-4. PubMed ID: 10490070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of doxacurium chloride (BW A938U) in children.
    Sarner JB; Brandom BW; Cook DR; Dong ML; Horn MC; Woelfel SK; Davis PJ; Rudd GD; Foster VJ; McNulty BF
    Anesth Analg; 1988 Apr; 67(4):303-6. PubMed ID: 2965532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration-effect relationship of cisatracurium at three different dose levels in the anesthetized patient.
    Bergeron L; Bevan DR; Berrill A; Kahwaji R; Varin F
    Anesthesiology; 2001 Aug; 95(2):314-23. PubMed ID: 11506100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.